Recipient:

1. A history of hypersensitivity to blood transfusions or its products

2. History of IgA deficiency

3. Heart failure or any other factor that prevents the transmission of of 500 ml plasma

4. Entering the intubation stage

Donator:

1. Patients infected with blood-borne viral / infectious diseases

2. Underlying heart disease, low or high blood pressure, diabetes, epilepsy, and anything that may prohibit blood donation.

3. Use of banned drugs for blood donation (eg, ethertinate, acitretin, aliotretinoin, isotretinoin, antiandrogens, NSAIDs, etc.)

4. Use of different drugs

5. Other prohibited donations based on blood transfusion standards

Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial